Press "Enter" to skip to content

Lilly’s new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions

Eli Lilly and Co has pulled ahead in a three-way race with Amgen Inc and Teva Pharmaceutical Industries Ltd in attracting new patients to a new class of migraine drugs, and seeks to build on that advantage by stressing that its therapy can completely prevent headaches in a small percentage of patients.

Original source: http://feeds.reuters.com/~r/reuters/INhealth/~3/MELGsgt_97I/lillys-new-migraine-drug-pulls-ahead-of-amgen-in-fierce-battle-for-new-prescriptions-idINKCN1SG28C

Also Read:   J&J recalls 33,000 bottles of baby powder as FDA finds asbestos in sample